JAVIER
MOLEÓN MOYA
Investigador en el periodo 2024-2024
Instituto de Investigación Biosanitaria de Granada
Granada, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Biosanitaria de Granada (9)
2023
-
Metabolic Modulators in Cardiovascular Complications of Systemic Lupus Erythematosus
Biomedicines, Vol. 11, Núm. 12
-
Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats
Biomedicine and Pharmacotherapy, Vol. 158
-
Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation
Pharmacological Research, Vol. 198
-
Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study
Gut Microbes, Vol. 15, Núm. 2
2022
-
Trimethylamine n-oxide promotes autoimmunity and a loss of vascular function in toll-like receptor 7-driven lupus mice
Antioxidants, Vol. 11, Núm. 1
2021
-
Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus
British Journal of Pharmacology, Vol. 178, Núm. 18, pp. 3708-3729
-
Gut microbiota has a crucial role in the development of hypertension and vascular dysfunction in toll-like receptor 7-driven lupus autoimmunity
Antioxidants, Vol. 10, Núm. 9
-
Probiotics prevent hypertension in a murine model of systemic lupus erythematosus induced by toll-like receptor 7 activation
Nutrients, Vol. 13, Núm. 8
2020
-
Mycophenolate improves brain–gut axis inducing remodeling of gut microbiota in doca-salt hypertensive rats
Antioxidants, Vol. 9, Núm. 12, pp. 1-18